Does SECUKINUMAB Cause Hepatic cirrhosis? 694 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 694 reports of Hepatic cirrhosis have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.5% of all adverse event reports for SECUKINUMAB.
694
Reports of Hepatic cirrhosis with SECUKINUMAB
0.5%
of all SECUKINUMAB reports
437
Deaths
453
Hospitalizations
How Dangerous Is Hepatic cirrhosis From SECUKINUMAB?
Of the 694 reports, 437 (63.0%) resulted in death, 453 (65.3%) required hospitalization, and 391 (56.3%) were considered life-threatening.
Is Hepatic cirrhosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 694 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Hepatic cirrhosis?
ADALIMUMAB (1,760)
METHOTREXATE (1,650)
ETANERCEPT (931)
TOCILIZUMAB (903)
RITUXIMAB (863)
INFLIXIMAB (831)
ABATACEPT (824)
HYDROXYCHLOROQUINE (807)
LEFLUNOMIDE (780)
SULFASALAZINE (760)
Which SECUKINUMAB Alternatives Have Lower Hepatic cirrhosis Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG